Molecular Mechanisms and Risk Factors Related to the Pathogenesis of Peyronie's Disease

Y Mitsui, F Yamabe, S Hori, M Uetani… - International Journal of …, 2023 - mdpi.com
Peyronie's disease (PD) is a benign condition caused by plaque formation on the tunica
albuginea of the penis. It is associated with penile pain, curvature, and shortening, and …

Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's Disease: A retrospective cohort …

E Durukan, R Kraglund, SA Rashid… - International Journal of …, 2024 - nature.com
Abstract Treatment with Phosphodiesterase Type 5 inhibitors (PDE5is) has shown promise
in managing Peyronie's disease (PD) during its active phase. In a retrospective cohort study …

[HTML][HTML] Comparison of Current International Guidelines on Premature Ejaculation: 2024 Update

L Romano, D Arcaniolo, L Spirito, C Quattrone… - Diagnostics, 2024 - mdpi.com
Premature ejaculation (PE) is a common male sexual dysfunction that can cause significant
distress in the patient and partner. This study aimed to compare the current international …

Commentary on “Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's disease: a …

C Manfredi, E Bologna, LC Licari - International Journal of Impotence …, 2024 - nature.com
In an article recently published in the International Journal of Impotence Research, Durukan
et al. evaluated the impact on penile curvature and pain duration of Phosphodiesterase …

Voice assistants as consultants for male patients with sexual Dysfunction: A reliable option?

L Napolitano, B Barone, L Spirito, F Trama… - International Journal of …, 2023 - mdpi.com
The aim of this study was to evaluate the ability of Google Assistant, Alexa, and Siri to
recognize and answer questions about male sexual health. Each VA was tested on a smart …

Long-term outcomes of extracorporeal shock wave therapy for acute Peyronie's disease: a 10-year retrospective analysis

L Spirito, C Manfredi, R La Rocca… - International Journal of …, 2024 - nature.com
The aim of this paper was to describe the long-term outcomes of extracorporeal shock wave
therapy (ESWT) in patients with acute Peyronie'disease (PD). An observational retrospective …

[PDF][PDF] EAU Guidelines

A Salonia, C Bettocchi, P Capogrosso… - The EAU Annual …, 2023 - medamorhealth.com
EAU Guidelines on Page 1 A. Salonia (Chair), C. Bettocchi, P. Capogrosso, J. Carvalho, G.
Corona, G. Hatzichristodoulou, TH Jones, A. Kadioglu, JI Martinez-Salamanca,S. Minhas (Vice-chair) …

Is there a new role for oral therapy to treat peyronie's disease? Commentary on Daily low-dose tadalafil may reduce the penile curvature progression rate in patients …

M Ziegelmann - International Journal of Impotence Research, 2024 - nature.com
In their article published in this months issue of International Journal of Impotence Research,
Spirito et al. sought to evaluate the impact of low dose oral tadalafil on the rate of penile …

A combination of phosphodiesterase type 5 inhibitor and tamoxifen for acute Peyronie's disease: the first clinical signals

S Cellek, M Megson, MM Ilg… - The Journal of Sexual …, 2023 - academic.oup.com
Peyronie's disease (PD) is a fibrotic disorder of the penile tunica albuginea (TA) and can
lead to pain during erection and/or intercourse, penile curvature, erectile dysfunction, and …

Unveiling treatment horizons and contemporary perspectives in Peyronie's disease–take home messages from Laurance A. Levine special issue

LA Levine - International Journal of Impotence Research, 2024 - nature.com
This special issue of IJIR: Your Sexual Medicine Journal focuses on Peyronie's disease
(PD). A more common than previously thought and very troubling disorder for the effected …